Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|March 4, 2005
Synthesis of NO-donor bisphosphonates and their in-vitro action on bone resorptionLoretta Lazzarato, Barbara Rolando, Marco L Lolli, et al.Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory DrugsFederica Sodano, Claudia Cristiano, Barbara Rolando, et al.Journal of Medicinal Chemistry|April 30, 2004
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist propertiesSonja Visentin, Barbara Rolando, Antonella Di Stilo, et al.Journal of Medicinal Chemistry|March 6, 2007
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator propertiesKonstantin Chegaev, Loretta Lazzarato, Paolo Tosco, et al.Journal of Medicinal Chemistry|December 31, 2008
Edaravone derivatives containing NO-donor functionsKonstantin Chegaev, Clara Cena, Marta Giorgis, et al.Molecular Pharmaceutics|July 25, 2014
Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cellsIsabella Pedrini, Elena Gazzano, Konstantin Chegaev, et al.Chemmedchem|April 11, 2018
Tuning the Hydrophobicity of a Mitochondria-Targeted NO PhotodonorFederica Sodano, Barbara Rolando, Francesca Spyrakis, et al.Chemmedchem|December 22, 2006
Amphiphilic NO-donor antioxidantsKonstantin Chegaev, Loretta Lazzarato, Barbara Rolando, et al.European Journal of Medicinal Chemistry|October 2, 2020
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cellsMarialessandra Contino, Stefano Guglielmo, Chiara Riganti, et al.Journal of Medicinal Chemistry|June 22, 2011
New nitric oxide or hydrogen sulfide releasing aspirinsLoretta Lazzarato, Konstantin Chegaev, Elisabetta Marini, et al.Pageof 11